|
Mr. Pucci joined ArQule in June 2008 from Bayer A.G. where he served as senior vice president and president in charge of the Bayer-Schering Pharmaceuticals Global Oncology/Specialized Therapeutics Business Units. Previously Mr. Pucci was senior vice president and president of Bayer Pharmaceuticals Global Specialty Business Unit head of U.S. Pharmaceutical Operations and a member of the Bayer Pharmaceuticals Global Management Committee. At Bayer Mr. Pucci was involved in a broad range of activities related to Nexavar® (sorafenib) an oral multiple kinase inhibitor to treat liver and kidney cancers. These activities included clinical development regulatory review corporate alliance management product launch and marketing. Mr. Pucci joined Bayer as head of its Italian Pharmaceutical operations in 2001. Prior to Bayer Mr. Pucci held positions of increasing responsibility with Eli Lilly culminating with his appointment as managing director Eli Lilly Sweden AB. At Lilly his responsibilities included operations sales marketing and strategic planning. Mr. Pucci holds an MBA from the University of Chicago and is a graduate of the Universita Degli Studi Di Napoli in Naples Italy.
| 